首页 > 最新文献

中国现代神经疾病杂志最新文献

英文 中文
Interpretation of "Chinese classification of cerebrovascular diseases (2015)" 解读《中国脑血管病分类(2015)》
Q4 Medicine Pub Date : 2017-12-25 DOI: 10.3969/CJCNN.V17I12.1700
Yan Chen, Fangfei Hu, Bo Wu
Chinese classification of cerebrovascular diseases (2015), published in 2017, attracts much attention. Cerebrovascular diseases are separated into 13 categories according to their etiology, pathogenesis, lesion arteries, lesion sites, clinical manifestations and complications. Some new contents or differences are discussed and compared with the earlier version, which is expected to acquire deeper comprehension and make better choices of clinical work. DOI: 10.3969/j.issn.1672-6731.2017.12.002
2017年发表的《中国脑血管病分类(2015)》备受关注。脑血管病根据其病因、发病机制、病变动脉、病变部位、临床表现和并发症可分为13类。对一些新的内容或差异进行了讨论,并与早期版本进行了比较,以期获得更深入的理解,更好地选择临床工作。DOI:10.3969/j.issn.1672-6731017.12.002
{"title":"Interpretation of \"Chinese classification of cerebrovascular diseases (2015)\"","authors":"Yan Chen, Fangfei Hu, Bo Wu","doi":"10.3969/CJCNN.V17I12.1700","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I12.1700","url":null,"abstract":"Chinese classification of cerebrovascular diseases (2015), published in 2017, attracts much attention. Cerebrovascular diseases are separated into 13 categories according to their etiology, pathogenesis, lesion arteries, lesion sites, clinical manifestations and complications. Some new contents or differences are discussed and compared with the earlier version, which is expected to acquire deeper comprehension and make better choices of clinical work. DOI: 10.3969/j.issn.1672-6731.2017.12.002","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"865-868"},"PeriodicalIF":0.0,"publicationDate":"2017-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44574688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Analysis on risk factors for post-stroke emotional incontinence 脑卒中后情绪失禁危险因素分析
Q4 Medicine Pub Date : 2017-12-25 DOI: 10.3969/CJCNN.V17I12.1708
Xiao-chun Zhang, Xinguo Yuan, Yu-rong Zhang, Le Zhang, Xiao-li Liu, Juan Zhang, Guo-Gang Luo
Objective To investigate the occurrence rate and related risk factors for post-stroke emotional incontinence (PSEI).  Methods The clinical data [sex, age, body mass index (BMI), education, marital status, medical history (hypertension, heart disease, diabetes, hyperlipemia, smoking and drinking) and family history of stroke] of 162 stroke patients were recorded. Serum homocysteine (Hcy) level was examined. Head CT and/or MRI were used to indicate stroke subtype, site of lesion and number of lesion. Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-Ⅴ) Chinese version and Hamilton Depression Rating Scale-17 Items (HAMD-17) were used to evaluate the degree of depression. House diagnostic standard was used to diagnose PSEI. Univariate and multivariate backward Logistic regression analysis was used to screen related risk factor for PSEI. Spearman rank correlation analysis was used to discuss the correlation between PSEI and post-stroke depression (PSD).  Results Among 162 stroke patients, 12 cases were diagnosed as PSEI (7.41% ). The ratio of age < 60 years in PSEI group was significantly higher than non-PSEI group ( P = 0.045). The ratio of smoking in PSEI group was significantly lower than non-PSEI group ( P = 0.036). Univariate and multivariate backward Logistic regression analysis showed age < 60 years was independent risk factor for PSEI ( OR = 4.000, 95%CI: 1.149-13.924; P = 0.029). Ten cases were combined with PSD in 12 PSEI patients, and the co-morbidity rate of PSEI and PSD was83.33%. Spearman rank correlation analysis showed PSEI was positively related to PSD ( r s = 0.305, P = 0.000).  Conclusions PSEI is common affective disorder in stroke patients, which easily happens in patients under 60 years of age. DOI: 10.3969/j.issn.1672-6731.2017.12.010
目的探讨脑卒中后情绪失禁(PSEI)的发生率及相关危险因素。方法记录162例脑卒中患者的临床资料[性别、年龄、体重指数(BMI)、文化程度、婚姻状况、病史(高血压、心脏病、糖尿病、高脂血症、吸烟、饮酒)及脑卒中家族史]。检测血清同型半胱氨酸(Hcy)水平。头部CT和/或MRI显示脑卒中亚型、病变部位和病变数量。采用《精神障碍诊断与统计手册》第五版(DSM-Ⅴ)中文版和汉密尔顿抑郁评定量表-17项(HAMD-17)进行抑郁程度评定。采用House诊断标准诊断PSEI。采用单因素和多因素Logistic回归分析筛选PSEI的相关危险因素。采用Spearman秩相关分析探讨PSEI与脑卒中后抑郁(PSD)的相关性。结果162例脑卒中患者中,有12例被诊断为PSEI,占7.41%。PSEI组年龄< 60岁的比例显著高于非PSEI组(P = 0.045)。PSEI组吸烟比例显著低于非PSEI组(P = 0.036)。单因素和多因素Logistic回归分析显示,年龄< 60岁是PSEI的独立危险因素(OR = 4.000, 95%CI: 1.149 ~ 13.924;P = 0.029)。12例PSEI患者中合并PSD 10例,合并PSD的发生率为83.33%。Spearman秩相关分析显示,PSEI与PSD呈正相关(r s = 0.305, P = 0.000)。结论PSEI是脑卒中患者常见的情感性障碍,60岁以下患者易发生。DOI: 10.3969 / j.issn.1672-6731.2017.12.010
{"title":"Analysis on risk factors for post-stroke emotional incontinence","authors":"Xiao-chun Zhang, Xinguo Yuan, Yu-rong Zhang, Le Zhang, Xiao-li Liu, Juan Zhang, Guo-Gang Luo","doi":"10.3969/CJCNN.V17I12.1708","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I12.1708","url":null,"abstract":"Objective To investigate the occurrence rate and related risk factors for post-stroke emotional incontinence (PSEI).  Methods The clinical data [sex, age, body mass index (BMI), education, marital status, medical history (hypertension, heart disease, diabetes, hyperlipemia, smoking and drinking) and family history of stroke] of 162 stroke patients were recorded. Serum homocysteine (Hcy) level was examined. Head CT and/or MRI were used to indicate stroke subtype, site of lesion and number of lesion. Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-Ⅴ) Chinese version and Hamilton Depression Rating Scale-17 Items (HAMD-17) were used to evaluate the degree of depression. House diagnostic standard was used to diagnose PSEI. Univariate and multivariate backward Logistic regression analysis was used to screen related risk factor for PSEI. Spearman rank correlation analysis was used to discuss the correlation between PSEI and post-stroke depression (PSD).  Results Among 162 stroke patients, 12 cases were diagnosed as PSEI (7.41% ). The ratio of age < 60 years in PSEI group was significantly higher than non-PSEI group ( P = 0.045). The ratio of smoking in PSEI group was significantly lower than non-PSEI group ( P = 0.036). Univariate and multivariate backward Logistic regression analysis showed age < 60 years was independent risk factor for PSEI ( OR = 4.000, 95%CI: 1.149-13.924; P = 0.029). Ten cases were combined with PSD in 12 PSEI patients, and the co-morbidity rate of PSEI and PSD was83.33%. Spearman rank correlation analysis showed PSEI was positively related to PSD ( r s = 0.305, P = 0.000).  Conclusions PSEI is common affective disorder in stroke patients, which easily happens in patients under 60 years of age. DOI: 10.3969/j.issn.1672-6731.2017.12.010","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"917-923"},"PeriodicalIF":0.0,"publicationDate":"2017-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44924141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Talk after spring: current status of stroke and therapeutics in acute phase 春后谈:急性期脑卒中现状及治疗方法
Q4 Medicine Pub Date : 2017-12-25 DOI: 10.3969/CJCNN.V17I12.1699
Jun Wang
{"title":"Talk after spring: current status of stroke and therapeutics in acute phase","authors":"Jun Wang","doi":"10.3969/CJCNN.V17I12.1699","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I12.1699","url":null,"abstract":"","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"861-864"},"PeriodicalIF":0.0,"publicationDate":"2017-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44942519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic study on moyamoya disease 烟雾病的遗传学研究
Q4 Medicine Pub Date : 2017-12-25 DOI: 10.3969/CJCNN.V17I12.1710
Li Zhou, Qiao-Shu Wang
Moyamoya disease (MMD) is a chronic progressive obstructive cerebrovascular disease. At present, the etiology and pathogenesis of MMD are still not clear. Recently, many studies confirmed the genetic susceptibility of MMD and reported that the genetic factors are more important than acquired causes. We summarize the domestic and foreign studies on the genetics of MMD, and expect to provide a guidance for early diagnosis and precise treatment. DOI: 10.3969/j.issn.1672-6731.2017.12.012
烟雾病(MMD)是一种慢性进行性阻塞性脑血管病。目前,MMD的病因和发病机制尚不清楚。近年来,许多研究证实了MMD的遗传易感性,并报道了遗传因素比后天原因更重要。我们总结了国内外对MMD遗传学的研究,希望为MMD的早期诊断和精确治疗提供指导。DOI:10.3969/j.issn.1672-6731017.12.012
{"title":"Genetic study on moyamoya disease","authors":"Li Zhou, Qiao-Shu Wang","doi":"10.3969/CJCNN.V17I12.1710","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I12.1710","url":null,"abstract":"Moyamoya disease (MMD) is a chronic progressive obstructive cerebrovascular disease. At present, the etiology and pathogenesis of MMD are still not clear. Recently, many studies confirmed the genetic susceptibility of MMD and reported that the genetic factors are more important than acquired causes. We summarize the domestic and foreign studies on the genetics of MMD, and expect to provide a guidance for early diagnosis and precise treatment. DOI: 10.3969/j.issn.1672-6731.2017.12.012","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"929-932"},"PeriodicalIF":0.0,"publicationDate":"2017-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49497664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse midline glioma, H3 K27M-mutant 弥漫性中线胶质瘤,H3 k27m突变体
Q4 Medicine Pub Date : 2017-12-25 DOI: 10.3969/CJCNN.V17I12.1713
Xiao-ling Yan
{"title":"Diffuse midline glioma, H3 K27M-mutant","authors":"Xiao-ling Yan","doi":"10.3969/CJCNN.V17I12.1713","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I12.1713","url":null,"abstract":"","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"936"},"PeriodicalIF":0.0,"publicationDate":"2017-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47678873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Analysis on early clinical features of behavioral variant frontotemporal dementia 行为变异性额颞叶痴呆的早期临床特征分析
Q4 Medicine Pub Date : 2017-11-25 DOI: 10.3969/CJCNN.V17I11.1692
Guan-jun Li, Jun Xu, Gang Mei, Ling Yue, Jing-hua Wang, Huafang Li
Background Although the early behavioral symptoms of behavioral variant frontotemporal dementia (bvFTD) are prominent, early diagnosis for bvFTD is difficult due to confusion with other mental disorders, and lack of sensitivity and specificity of diagnostic criteria, etc. In this paper, we summarized the important reviews in recent years and analyzed the clinical characteristics of bvFTD patients to improve the detection of early symptoms in bvFTD.  Methods Twenty-three possible or probable bvFTD patients were diagnosed according to International Behavioral Variant Frontotemporal Dementia Criteria Consortium (FTDC). Self-designed questionnaires designed by Shanghai Mental Health Center were used to collect sociodemographic data and general information of patients. Their clinical characteristics were summarized, including abnormal behaviors, cognitive impairment, psychotic symptoms and other symptoms. Mini-Mental State Examination (MMSE), Activities of Daily Living (ADL) and Clinical Dementia Rating Scale (CDR) were used to make neuropsychological tests and compare with similar overseas studies (control group, N = 66).  Results Eleven male patients and 12 female patients were included in our study. Compared with control group, the average age of onset [(50.83 ± 11.55) years vs. (57.00 ± 10.00) years; t = 3.863, P = 0.000] and average age of diagnosis [(53.22 ± 11.55) years vs. (61.00 ± 9.00) years;  t = 13.423,  P = 0.000] of bvFTD patients were smaller. The study showed that bvFTD patients had more apathy or indolence [95.65% (22/23) vs. 65.15% (43/66); χ 2 = 8.057,  P = 0.005], loss of sympathy or empathy [95.65% (22/23) vs. 33.33% (22/66); χ 2 = 26.499,  P = 0.000], while patients in control group showed more derepression behavior [98.48% (65/66) vs. 52.17% (12/23); χ 2 = 27.514,  P = 0.000] and continuous, stiff, obsessive and/or ritualized behavior [95.45% (63/66) vs. 30.43% (7/23); adjusted χ 2 = 39.159,  P = 0.000]. For cognitive impairment, bvFTD patients presented apraxia [69.56% (16/23) vs. 22.73% (15/66); χ 2 = 16.484,  P = 0.000] and executive dysfunction [82.61% (19/23) vs. 59.09% (39/66); χ 2 = 4.156,  P = 0.041]. In psychotic symptoms, patients in control group showed hallucination and delusion [33.33% (22/66) vs. 4.35% (1/23); χ 2 = 7.477,  P = 0.006].  Conclusions While the behavioral symptoms of bvFTD patients are varied, memory disorder can be one of the primal symptoms. Compared with similar foreign studies, the different composition of behavior symptoms of our bvFTD patients may be caused by cultural differences among evaluators in the understanding of some clinical symptoms in patients. DOI: 10.3969/j.issn.1672-6731.2017.11.010
背景尽管行为变异性额颞叶痴呆(bvFTD)的早期行为症状突出,但由于与其他精神障碍混淆,诊断标准缺乏敏感性和特异性等原因,bvFTD的早期诊断很困难,我们总结了近年来的重要综述,并分析了bvFTD患者的临床特征,以提高对bvFTD早期症状的检测。方法根据国际行为变异性额颞叶痴呆标准联合会(FTDC)对23例可能或可能的bvFTD患者进行诊断。采用上海市精神卫生中心自行设计的调查表,收集患者的社会人口学资料和一般信息。总结其临床特点,包括行为异常、认知障碍、精神病症状等。采用简易精神状态检查(MMSE)、日常生活能力(ADL)和临床痴呆评定量表(CDR)进行神经心理测试,并与国外类似研究进行比较(对照组,N=66)。结果11例男性患者和12例女性患者被纳入本研究。与对照组相比,bvFTD患者的平均发病年龄[(50.83±11.55)岁对(57.00±10.00)岁;t=3.863,P=0.000]和平均诊断年龄[(53.22±11.5 5)年对(61.00±9.00)年;t=13.423,P=0.0000]较小。研究表明,bvFTD患者表现出更多的冷漠或懒惰[95.65%(22/23)vs.65.15%(43/66);χ2=8.057,P=0.005],失去同情或同理心[95.65%,22/23)vs 33.33%(22/66),强迫和/或仪式化行为[95.45%(63/66)vs.30.43%(7/23);校正后的χ2=39.159,P=0.000]。对于认知障碍,bvFTD患者表现为失用症[69.56%(16/23)vs.22.73%(15/66);χ2=16.484,P=0.0000]和执行功能障碍[82.61%(19/23)vs.59.09%(39/66);χ0=4.156,P=0.041]。在精神病症状中,对照组患者出现幻觉和妄想[33.33%(22/66)vs.4.35%(1/23);χ2=7.477,P=0.006]。与国外类似研究相比,我们bvFTD患者行为症状组成的不同可能是由于评估者对患者某些临床症状的理解存在文化差异所致。DOI:10.3969/j.issn.1672-6731017.11.010
{"title":"Analysis on early clinical features of behavioral variant frontotemporal dementia","authors":"Guan-jun Li, Jun Xu, Gang Mei, Ling Yue, Jing-hua Wang, Huafang Li","doi":"10.3969/CJCNN.V17I11.1692","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I11.1692","url":null,"abstract":"Background Although the early behavioral symptoms of behavioral variant frontotemporal dementia (bvFTD) are prominent, early diagnosis for bvFTD is difficult due to confusion with other mental disorders, and lack of sensitivity and specificity of diagnostic criteria, etc. In this paper, we summarized the important reviews in recent years and analyzed the clinical characteristics of bvFTD patients to improve the detection of early symptoms in bvFTD.  Methods Twenty-three possible or probable bvFTD patients were diagnosed according to International Behavioral Variant Frontotemporal Dementia Criteria Consortium (FTDC). Self-designed questionnaires designed by Shanghai Mental Health Center were used to collect sociodemographic data and general information of patients. Their clinical characteristics were summarized, including abnormal behaviors, cognitive impairment, psychotic symptoms and other symptoms. Mini-Mental State Examination (MMSE), Activities of Daily Living (ADL) and Clinical Dementia Rating Scale (CDR) were used to make neuropsychological tests and compare with similar overseas studies (control group, N = 66).  Results Eleven male patients and 12 female patients were included in our study. Compared with control group, the average age of onset [(50.83 ± 11.55) years vs. (57.00 ± 10.00) years; t = 3.863, P = 0.000] and average age of diagnosis [(53.22 ± 11.55) years vs. (61.00 ± 9.00) years;  t = 13.423,  P = 0.000] of bvFTD patients were smaller. The study showed that bvFTD patients had more apathy or indolence [95.65% (22/23) vs. 65.15% (43/66); χ 2 = 8.057,  P = 0.005], loss of sympathy or empathy [95.65% (22/23) vs. 33.33% (22/66); χ 2 = 26.499,  P = 0.000], while patients in control group showed more derepression behavior [98.48% (65/66) vs. 52.17% (12/23); χ 2 = 27.514,  P = 0.000] and continuous, stiff, obsessive and/or ritualized behavior [95.45% (63/66) vs. 30.43% (7/23); adjusted χ 2 = 39.159,  P = 0.000]. For cognitive impairment, bvFTD patients presented apraxia [69.56% (16/23) vs. 22.73% (15/66); χ 2 = 16.484,  P = 0.000] and executive dysfunction [82.61% (19/23) vs. 59.09% (39/66); χ 2 = 4.156,  P = 0.041]. In psychotic symptoms, patients in control group showed hallucination and delusion [33.33% (22/66) vs. 4.35% (1/23); χ 2 = 7.477,  P = 0.006].  Conclusions While the behavioral symptoms of bvFTD patients are varied, memory disorder can be one of the primal symptoms. Compared with similar foreign studies, the different composition of behavior symptoms of our bvFTD patients may be caused by cultural differences among evaluators in the understanding of some clinical symptoms in patients. DOI: 10.3969/j.issn.1672-6731.2017.11.010","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"834-839"},"PeriodicalIF":0.0,"publicationDate":"2017-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41641133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meningoencephalomyelitis associated with Epstein-Barr virus infection: one case report EB病毒感染并发脑脊髓炎1例报告
Q4 Medicine Pub Date : 2017-11-25 DOI: 10.3969/cjcnn.v17i11.1696
Dandan Song, Qingqing Wang, Q. Guo, X. Qi, F. Qiu
{"title":"Meningoencephalomyelitis associated with Epstein-Barr virus infection: one case report","authors":"Dandan Song, Qingqing Wang, Q. Guo, X. Qi, F. Qiu","doi":"10.3969/cjcnn.v17i11.1696","DOIUrl":"https://doi.org/10.3969/cjcnn.v17i11.1696","url":null,"abstract":"","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"856-859"},"PeriodicalIF":0.0,"publicationDate":"2017-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49168803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clear cell ependymoma 透明细胞室管膜瘤
Q4 Medicine Pub Date : 2017-11-25 DOI: 10.3969/CJCNN.V17I11.1697
Xiao-ling Yan
{"title":"Clear cell ependymoma","authors":"Xiao-ling Yan","doi":"10.3969/CJCNN.V17I11.1697","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I11.1697","url":null,"abstract":"","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"833"},"PeriodicalIF":0.0,"publicationDate":"2017-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46163683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thrombectomy with Solitaire stent for treating acute middle cerebral artery occlusion Solitaire支架血栓切除术治疗急性大脑中动脉闭塞
Q4 Medicine Pub Date : 2017-11-25 DOI: 10.3969/CJCNN.V17I11.1686
Xiao-hui Chen, Meng-fei Zhong, Zhi-jie Yang, Zai-gang Lü, Mengxiao Liu, Hai-ting Li, Xiuyan Chen, Zong-en Gao
Objective To assess the efficacy and safety of thrombectomy with Solitaire stent for treatment of acute middle cerebral artery occlusion (MCAO), and to identify the predictive factors for clinical outcome.  Methods A total of 25 patients with acute middle cerebral artery (MCA)-M1 segment occlusion were treated by thrombectomy with Solitaire stent. Time from onset to femoral artery puncture, time from femoral artery puncture to recanalization, times of thrombectomy, thrombolytic therapy or not, balloon dilatation and/or stent implantation, intraarterial thrombolysis or not, tirofiban treatment after therapy or not were recorded. Vascular recanalization immediately after procedure was evaluated by Thrombolysis in Cerebral Infarction (TICI). National Institutes of Health Stroke Scale (NIHSS) was used to evaluate neurological function of patients 24 h after operation, and the clinical outcomes were assessed by modified Rankin Scale (mRS) at 90 d after treatment. The occurrence rate of symptomatic intracranial hemorrhage within 24 h after operation and mortality within 90 d after treatment were recorded.  Results Median time from onset to femoral artery puncture was 5.00 (4.00, 6.30) h; median time from femoral artery puncture to recanalization was 2.00 (2.00, 2.50) h; times of thrombectomy was 2 (2, 2); 7 patients (28%) received intravenous thrombolysis before thrombectomy; 6 patients (24%) underwent balloon dilatation only; 3 patients (12%) underwent stent implantation only; 4 patients (16%) underwent balloon dilatation and stent implantation; 4 patients (16%) received intraarterial thrombolysis after thrombectomy; 11 (44%) received tirofiban therapy after operation. There were 20 patients (80% ) of recanalization with TICI 2b-3 grade. The NIHSS score at 24 h after operation was significantly decreased than before procedure [8 (4, 12) score vs. 14 (11, 17) score; Z = -3.532, P = 0.000]. Symptomatic intracranial hemorrhage occurred in 3 patients (12%). At 90 d after treatment, 15 patients (60%) had favorable prognosis (mRS ≤ 2 score). Two patients (8%) died. Univariate and multivariate forward Logistic regression analysis showed the TICI 2b-3 grade was independent factor for favorable prognosis ( OR = 0.316, 95% CI: 0.102-0.982; P = 0.046).  Conclusions Thrombectomy with Solitaire stent is safe and effective for treating acute MCAO. With the increase of TICI grade, the prognosis is better. DOI: 10.3969/j.issn.1672-6731.2017.11.004
目的评价Solitaire支架取栓治疗急性大脑中动脉闭塞(MCAO)的疗效和安全性,并探讨其临床预后的预测因素。方法对25例急性大脑中动脉(MCA)-M1段闭塞患者行支架取栓术。记录从发病至股动脉穿刺时间、股动脉穿刺至再通时间、取栓次数、是否溶栓、球囊扩张及/或支架置入术、是否动脉溶栓、治疗后是否使用替罗非班。手术后立即血管再通通过脑梗死溶栓(TICI)进行评估。术后24 h采用美国国立卫生研究院卒中量表(NIHSS)评估患者神经功能,治疗后90 d采用改良Rankin量表(mRS)评估临床疗效。记录术后24 h内症状性颅内出血发生率及治疗后90 d内病死率。结果从发病到穿刺股动脉的中位时间为5.00 (4.00,6.30)h;从股动脉穿刺到再通的中位时间为2.00 (2.00,2.50)h;取栓次数为2次(2,2);取栓前静脉溶栓7例(28%);6例(24%)仅行球囊扩张术;仅行支架植入术3例(12%);行球囊扩张及支架置入术4例(16%);取栓后行动脉溶栓4例(16%);11例(44%)术后接受替罗非班治疗。有20例患者(80%)再通,TICI为2b-3级。术后24 h NIHSS评分明显低于术前[8(4,12)分比14(11,17)分;Z = -3.532, p = 0.000]。出现症状性颅内出血3例(12%)。治疗后90 d, 15例(60%)患者预后良好(mRS≤2分)。2例(8%)死亡。单因素和多因素正向Logistic回归分析显示,TICI 2b-3分级是预后良好的独立因素(OR = 0.316, 95% CI: 0.102 ~ 0.982;P = 0.046)。结论支架取栓是治疗急性MCAO安全有效的方法。随着TICI分级的增加,预后较好。DOI: 10.3969 / j.issn.1672-6731.2017.11.004
{"title":"Thrombectomy with Solitaire stent for treating acute middle cerebral artery occlusion","authors":"Xiao-hui Chen, Meng-fei Zhong, Zhi-jie Yang, Zai-gang Lü, Mengxiao Liu, Hai-ting Li, Xiuyan Chen, Zong-en Gao","doi":"10.3969/CJCNN.V17I11.1686","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I11.1686","url":null,"abstract":"Objective To assess the efficacy and safety of thrombectomy with Solitaire stent for treatment of acute middle cerebral artery occlusion (MCAO), and to identify the predictive factors for clinical outcome.  Methods A total of 25 patients with acute middle cerebral artery (MCA)-M1 segment occlusion were treated by thrombectomy with Solitaire stent. Time from onset to femoral artery puncture, time from femoral artery puncture to recanalization, times of thrombectomy, thrombolytic therapy or not, balloon dilatation and/or stent implantation, intraarterial thrombolysis or not, tirofiban treatment after therapy or not were recorded. Vascular recanalization immediately after procedure was evaluated by Thrombolysis in Cerebral Infarction (TICI). National Institutes of Health Stroke Scale (NIHSS) was used to evaluate neurological function of patients 24 h after operation, and the clinical outcomes were assessed by modified Rankin Scale (mRS) at 90 d after treatment. The occurrence rate of symptomatic intracranial hemorrhage within 24 h after operation and mortality within 90 d after treatment were recorded.  Results Median time from onset to femoral artery puncture was 5.00 (4.00, 6.30) h; median time from femoral artery puncture to recanalization was 2.00 (2.00, 2.50) h; times of thrombectomy was 2 (2, 2); 7 patients (28%) received intravenous thrombolysis before thrombectomy; 6 patients (24%) underwent balloon dilatation only; 3 patients (12%) underwent stent implantation only; 4 patients (16%) underwent balloon dilatation and stent implantation; 4 patients (16%) received intraarterial thrombolysis after thrombectomy; 11 (44%) received tirofiban therapy after operation. There were 20 patients (80% ) of recanalization with TICI 2b-3 grade. The NIHSS score at 24 h after operation was significantly decreased than before procedure [8 (4, 12) score vs. 14 (11, 17) score; Z = -3.532, P = 0.000]. Symptomatic intracranial hemorrhage occurred in 3 patients (12%). At 90 d after treatment, 15 patients (60%) had favorable prognosis (mRS ≤ 2 score). Two patients (8%) died. Univariate and multivariate forward Logistic regression analysis showed the TICI 2b-3 grade was independent factor for favorable prognosis ( OR = 0.316, 95% CI: 0.102-0.982; P = 0.046).  Conclusions Thrombectomy with Solitaire stent is safe and effective for treating acute MCAO. With the increase of TICI grade, the prognosis is better. DOI: 10.3969/j.issn.1672-6731.2017.11.004","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"793-799"},"PeriodicalIF":0.0,"publicationDate":"2017-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45005650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collision tumor of the sellar region 鞍区碰撞瘤
Q4 Medicine Pub Date : 2017-11-25 DOI: 10.3969/CJCNN.V17I11.1691
J. Gong, Yan-yan Su, S. Lei, Xiao-Yu Liu, Shang-fu Zhang
Objective To summarize clinical and pathological features, diagnosis and differential diagnosis, as well as treatment and prognosis through analyzing one case of collision tumor in the sellar region (pituitary adenoma combined with malignant triton tumor).  Methods and Results A 59-year-old male was admitted to hospital with decreased vision, vision field defect and dizziness. Head MRI demonstrated space-occupying lesion in the sellar region. Therefore, the patient underwent a transsphenoidal surgery with subtotal tumor resection. Three months later, the patient was admitted to hospital again with vision loss and headache. Head CT demonstrated space-occupying lesions in sellar/suprasellar region, therefore, the patient underwent saddle tumor resection. Histological findings revealed that the tumor was composed of two different types of tumors, one was pituitary adenoma with epithelial cells arranged in nest-like and trabecular pattern, and the other was diffused spindle cell tumor. The two tumors were distributed separately or mixed togenther. The morphology of spindle cell tumor was bland with scarce mitosis in the first surgery, whereas additional features including increased cell density, dark nuclei, frequent mitosis and scattering distributed rhabdomyoblasts were found in the second surgery. Immunohistochemically, the pituitary adenoma (epithelial cell region) cells were positive for cytokeratin 8 (CK8), chromogranin A (CgA), synaptophysin (Syn) and thyroid stimulating hormone (TSH), while the malignant triton tumor cells (spindle cell region) were positive for CD56, CD57, calretinin (CR) and focally positive for S-100 protein (S-100), desmin (Des) and myogenin. Ultrastructural findings revealed abundant rough endoplasmic reticules and secretary granules in the cytoplasm of pituitary adenoma cells, and discontinuous basal lamina located outside the spindle cell membrane. The final pathological diagnosis was sellar collision tumor (non-functional TSH adenoma combined with malignant triton tumor). The patient died 6 months after the second surgery.  Conclusions Collision tumor of the sellar region with pituitary adenoma and malignant triton tumor is a rare tumor which can hardly be diagnosed by clinical and neuroimaging examination. The diagnosis relies on morphological characteristics, immunophenotype and ultrastructural features. The prognosis of collision tumor with malignant triton tumor component is poor. DOI: 10.3969/j.issn.1672-6731.2017.11.009
目的通过分析1例鞍区碰撞瘤(垂体腺瘤合并恶性甲状腺瘤)的临床病理特点、诊断与鉴别诊断、治疗及预后。方法与结果男性1例,59岁,因视力下降、视野缺损、头晕入院。头部MRI显示鞍区占位性病变。因此,患者接受了经蝶窦手术和肿瘤次全切除。3个月后,患者因视力下降和头痛再次入院。头部CT显示鞍区/鞍上区占位性病变,因此患者行鞍区肿瘤切除术。组织学结果显示,肿瘤由两种不同类型的肿瘤组成,一种是垂体腺瘤,上皮细胞呈巢状和小梁状排列,另一种是弥漫性梭形细胞瘤。两个肿瘤分别分布或混在一起。梭形细胞肿瘤在第一次手术中形态平淡,很少有丝分裂,而在第二次手术中发现细胞密度增加,细胞核暗,有丝分裂频繁,横纹肌母细胞分散分布。免疫组化结果显示,垂体腺瘤(上皮细胞区)细胞角蛋白8 (CK8)、嗜铬粒蛋白A (CgA)、突触素(Syn)、促甲状腺激素(TSH)阳性,而恶性triton肿瘤(梭形细胞区)细胞CD56、CD57、calretinin (CR)阳性,S-100蛋白(S-100)、desmin (Des)、肌原素(myogenin)局部阳性。超微结构显示垂体腺瘤细胞胞质内有丰富的粗面内质网和秘书颗粒,纺锤体细胞膜外有不连续的基底膜。最终病理诊断为鞍部碰撞瘤(无功能TSH腺瘤合并恶性triton瘤)。患者在第二次手术后6个月死亡。结论鞍区碰撞瘤合并垂体腺瘤及恶性三角瘤是一种罕见的肿瘤,临床及神经影像学检查难以诊断。诊断依赖于形态学特征、免疫表型和超微结构特征。碰撞瘤合并恶性triton肿瘤成分预后较差。DOI: 10.3969 / j.issn.1672-6731.2017.11.009
{"title":"Collision tumor of the sellar region","authors":"J. Gong, Yan-yan Su, S. Lei, Xiao-Yu Liu, Shang-fu Zhang","doi":"10.3969/CJCNN.V17I11.1691","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I11.1691","url":null,"abstract":"Objective To summarize clinical and pathological features, diagnosis and differential diagnosis, as well as treatment and prognosis through analyzing one case of collision tumor in the sellar region (pituitary adenoma combined with malignant triton tumor).  Methods and Results A 59-year-old male was admitted to hospital with decreased vision, vision field defect and dizziness. Head MRI demonstrated space-occupying lesion in the sellar region. Therefore, the patient underwent a transsphenoidal surgery with subtotal tumor resection. Three months later, the patient was admitted to hospital again with vision loss and headache. Head CT demonstrated space-occupying lesions in sellar/suprasellar region, therefore, the patient underwent saddle tumor resection. Histological findings revealed that the tumor was composed of two different types of tumors, one was pituitary adenoma with epithelial cells arranged in nest-like and trabecular pattern, and the other was diffused spindle cell tumor. The two tumors were distributed separately or mixed togenther. The morphology of spindle cell tumor was bland with scarce mitosis in the first surgery, whereas additional features including increased cell density, dark nuclei, frequent mitosis and scattering distributed rhabdomyoblasts were found in the second surgery. Immunohistochemically, the pituitary adenoma (epithelial cell region) cells were positive for cytokeratin 8 (CK8), chromogranin A (CgA), synaptophysin (Syn) and thyroid stimulating hormone (TSH), while the malignant triton tumor cells (spindle cell region) were positive for CD56, CD57, calretinin (CR) and focally positive for S-100 protein (S-100), desmin (Des) and myogenin. Ultrastructural findings revealed abundant rough endoplasmic reticules and secretary granules in the cytoplasm of pituitary adenoma cells, and discontinuous basal lamina located outside the spindle cell membrane. The final pathological diagnosis was sellar collision tumor (non-functional TSH adenoma combined with malignant triton tumor). The patient died 6 months after the second surgery.  Conclusions Collision tumor of the sellar region with pituitary adenoma and malignant triton tumor is a rare tumor which can hardly be diagnosed by clinical and neuroimaging examination. The diagnosis relies on morphological characteristics, immunophenotype and ultrastructural features. The prognosis of collision tumor with malignant triton tumor component is poor. DOI: 10.3969/j.issn.1672-6731.2017.11.009","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"825-833"},"PeriodicalIF":0.0,"publicationDate":"2017-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41997092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
中国现代神经疾病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1